Fengxia Liang
Overview
Explore the profile of Fengxia Liang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
1174
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang S, Chen L, Zhang H, Song Y, Wang W, Hu Z, et al.
J Neuroinflammation
. 2025 Mar;
22(1):75.
PMID: 40069822
Chronic urticaria (CU) arises from a multifaceted interplay of immunological, neurological, and psychological components. Immune dysregulation, mediated through both immunoglobulin E (IgE)-dependent and IgE-independent pathways, plays a pivotal role in...
2.
Zhou M, Niu H, Huang G, Zhou M, Cui D, Li H, et al.
Small
. 2024 Nov;
21(2):e2407191.
PMID: 39523731
Suppressing tumor metastasis is a crucial strategy for improving survival rates in patients with colorectal cancer (CRC), with cancer stem cells (CSCs) being the primary drivers of metastasis. Current therapeutic...
3.
Zhou M, Niu H, Lu D, Zhang H, Luo D, Yu Z, et al.
J Ethnopharmacol
. 2024 Nov;
338(Pt 1):118998.
PMID: 39489363
Ethnopharmacological Relevance: Wu Mei Wan (WMW) is a traditional Chinese herbal formula with a long-standing history in Chinese medicine, valued for its therapeutic properties. However, its potential anti-cancer effects, especially...
4.
Liang F, Liu L, Yuan Y, Meng Z, Zhang F, Cao Y
Arch Esp Urol
. 2024 Sep;
77(7):839-840.
PMID: 39238311
No abstract available.
5.
Tan W, Zhang J, Chen L, Wang Y, Chen R, Zhang H, et al.
Diabetes Obes Metab
. 2024 Sep;
26(11):4830-4845.
PMID: 39233500
Non-alcoholic fatty liver disease (NAFLD), a metabolic-associated fatty liver disease, has become the most common chronic liver disease worldwide. Recently, the discovery of cuproptosis, a newly identified mode of cell...
6.
Huang G, Zhou M, Lu D, Li J, Tang Q, Xiong C, et al.
Front Oncol
. 2024 Aug;
14:1421902.
PMID: 39169946
Integrin β4 (ITGB4) is a transmembrane protein that functions as a mechanosensor, mediating the bidirectional exchange of information between the intracellular and extracellular matrices. ITGB4 plays a critical role in...
7.
Yang Y, Zhou X, Deng H, Chen L, Zhang X, Wu S, et al.
Front Physiol
. 2024 Jun;
15:1416967.
PMID: 38915778
O-GlcNAcylation, as a post-translational modification, can modulate cellular activities such as kinase activity, transcription-translation, protein degradation, and insulin signaling by affecting the function of the protein substrate, including cellular localization...
8.
Zhou M, Niu H, Cui D, Huang G, Li J, Tian H, et al.
Phytother Res
. 2024 Apr;
38(6):3218-3239.
PMID: 38682953
Colorectal cancer (CRC) is a significant health problem with elevated mortality rates, prompting intense exploration of its complex molecular mechanisms and innovative therapeutic avenues. Resveratrol (RSV), recognised for its anticancer...
9.
Niu H, Zhou M, Zogona D, Xing Z, Wu T, Chen R, et al.
Front Immunol
. 2024 Apr;
15:1370658.
PMID: 38571945
Metabolic diseases are comprehensive disease based on obesity. Numerous cumulative studies have shown a certain correlation between the fluctuating abundance of and the occurrence of metabolic diseases. , a potential...
10.
Yu W, Zhou M, Niu H, Li J, Li Q, Xu X, et al.
BMC Cancer
. 2024 Jan;
24(1):140.
PMID: 38287266
Glioblastoma multiforme (GBM) is the most aggressive brain cancer with a poor prognosis. Therefore, the correlative molecular markers and molecular mechanisms should be explored to assess the occurrence and treatment...